Amedisys, for the fourth quarter of 2024, delivers year-over-year top-line growth across three of its segments - Home Health, Hospice and High Acuity Care. While the top- and bottom-line numbers ...

Amedisys, for the fourth quarter of 2024, delivers year-over-year top-line growth across three of its segments - Home Health, ...

Amedisys Inc. (Nasdaq: AMED) experienced growth in home health during the fourth quarter of 2024, despite incurring merger-related costs from its pending ...

Amedisys shares have risen nearly 1% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $91.57, a fall of roughly 3% in the last 12 months.

(2) Adjusted EBITDA is defined as net (loss) income attributable to Amedisys, Inc. before net interest expense, provision for income taxes and depreciation and amortization, excluding certain ...

Reports Q4 revenue $598.1M, consensus $602.38M. Discover the Best Stocks and Maximize Your Portfolio: See what stocks are receiving Strong ...

Truist Financial analyst David S Macdonald maintained a Hold rating on Amedisys (AMED – Research Report) today and set a price target of ...

BATON ROUGE, La. (AP) — BATON ROUGE, La. (AP) — Amedisys Inc. (AMED) on Wednesday reported a fourth-quarter loss of $20.4 million, after reporting a profit in the same period a year earlier. On a ...

BATON ROUGE, La. (AP) — BATON ROUGE, La. (AP) — Amedisys Inc. (AMED) on Wednesday reported a fourth-quarter loss of $20.4 million, after reporting a profit in the same period a year earlier.